- Cardiac Valve Diseases and Treatments
- Infective Endocarditis Diagnosis and Management
- Cardiac Imaging and Diagnostics
- Cardiac pacing and defibrillation studies
- Aortic Disease and Treatment Approaches
- Cardiovascular Function and Risk Factors
- Coronary Interventions and Diagnostics
- Mechanical Circulatory Support Devices
- Cardiac Structural Anomalies and Repair
- Cardiac, Anesthesia and Surgical Outcomes
- Acute Myocardial Infarction Research
- Cardiac Arrhythmias and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
- Heart Failure Treatment and Management
- Atrial Fibrillation Management and Outcomes
- Health Systems, Economic Evaluations, Quality of Life
- Cardiac and Coronary Surgery Techniques
- Transplantation: Methods and Outcomes
- Pulmonary Hypertension Research and Treatments
- Cardiac Arrest and Resuscitation
- Aortic aneurysm repair treatments
- Spine and Intervertebral Disc Pathology
- Efficiency Analysis Using DEA
- Sex and Gender in Healthcare
- Acute Ischemic Stroke Management
Michael E. DeBakey VA Medical Center
2023-2025
Baylor College of Medicine
2023-2025
Houston Methodist
2021-2024
Methodist Hospital
2021-2024
Baylor School
2024
Mount Sinai Health System
2018-2024
Mount Sinai Medical Center
2019-2023
G Pulla Reddy Dental College & Hospital
2023
Rochester General Hospital
2023
Westchester Medical Center
2016-2022
Background Edge-to-edge transcatheter mitral valve repair as salvage therapy in high surgical risk patients with severe regurgitation presenting cardiogenic shock (CS) has been described small case series, but large clinical results have not reported. This study aimed to evaluate outcomes of MitraClip and CS using a national database. Methods Results From January 2014 March 2019, we identified hospitalizations for disease data from Centers Medicare Medicaid Services. Those prior or...
There are limited data on the impact of transcatheter heart valve (THV) type outcomes surgical explantation after THV failure.
Abstract Background and Aims Surgical explantation of transcatheter heart valves (THVs) is rapidly increasing, but there are limited data on patients with THV-associated infective endocarditis (IE). This study aims to assess the outcomes undergoing THV explant for IE. Methods All who underwent between 2011 2022 from 44 sites in EXPLANT-TAVR registry were identified. Patients IE as reason compared those other mechanisms bioprosthetic valve dysfunction (BVD). Results A total 372 included....
Background: Currently, 2 third-generation transcatheter valves, 29-mm Sapien-3 and 34-mm Evolut-R (ER), are indicated for large sized aortic annuli. We analyzed short 1-year performance of these valves in patients with (area ≥575 mm or perimeter ≥85 mm) extra-large (≥683 ≥94.2 annuli undergoing valve replacement. Methods: A total 833 across 12 centers symptomatic stenosis underwent replacement (n=640) ER (n=193). Clinical, anatomic, procedural characteristics were collected, Valve Academic...